Not Medicare Enrolled

Dr. John Wood, MD

Family Medicine · Richardson, TX
970 N COIT RD STE 3040, Richardson, TX 75080
9722388092
Registered in NPPES since 2006
NPI: 1083648257 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wood? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wood

Dr. John Wood is a family medicine specialist in Richardson, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Wood received a total of $13,644 from 32 pharmaceutical and/or device companies across 244 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wood is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $13,644 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,644
Total received (2018-2024)
Avg $2,274/year across 6 years
Top 3% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
244
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$56
2023
$58
2022
$16
2021
$103
2019
$533
2018
$12,877

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$56
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$7,109
AstraZeneca Pharmaceuticals LP
$1,071
Boehringer Ingelheim Pharmaceuticals, Inc.
$481
Amgen Inc.
$470
Novo Nordisk Inc
$451
Merck Sharp & Dohme Corporation
$431
SANOFI-AVENTIS U.S. LLC
$382
Amarin Pharma Inc.
$373
Novartis Pharmaceuticals Corporation
$340
Janssen Pharmaceuticals, Inc
$336
AbbVie, Inc.
$278
Radius Health, Inc.
$250
Gilead Sciences, Inc.
$227
PFIZER INC.
$223
Lilly USA, LLC
$178
Kowa Pharmaceuticals America, Inc.
$157
Shire North American Group Inc
$147
Horizon Pharma plc
$144
Synergy Pharmaceuticals Inc
$131
Takeda Pharmaceuticals U.S.A., Inc.
$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
Allergan Inc.
$61
Circassia Pharmaceuticals Inc
$44
Sunovion Pharmaceuticals Inc.
$30
Nalpropion Pharmaceuticals, Inc.
$26
Promius Pharma LLC
$21
Astellas Pharma US Inc
$20
Melinta Therapeutics, Inc.
$18
Nalpropion Pharmaceuticals LLC
$17
Lupin Inc.
$14
Sanofi Pasteur Inc.
$14
Aytu BioScience, Inc
$11
Top 3 companies account for 63.5% of all-time payments
Associated products mentioned in payments ›
ADVAIR · ANORO · Aimovig · Androgel · BEVESPI AEROSPHERE · BREO · BYDUREON · BYSTOLIC · Baxdela · CHANTIX · CONTRAVE · COSENTYX · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · GARDASIL · INVOKANA · JANUVIA · JARDIANCE · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MYDAYIS · MYRBETRIQ · NO_PRODUCT · Natesto · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREVNAR - 13 · Prolia · Repatha · SHINGRIX · SIVEXTRO · SOLIQUA · STEGLATRO · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · Truvada · Tymlos · Utibron · VIBERZI · VYVANSE · Vascepa · Victoza · XARELTO · XIFAXAN · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a family medicine specialist in Richardson?
Compare family medicine physicians in the Richardson area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians in nearby ZIP areas
1,548
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
3.1 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wood is a family medicine specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Wood receive payments from pharmaceutical companies?
Yes. Dr. Wood received a total of $13,644 from 32 companies across 244 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Wood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Richardson
Browse family medicine physicians in Richardson ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →